BridgeMD
New treatment option for Cerebral Palsy
Official title Telemedicine in Early Childhood Constraint Therapy in Cerebral Palsy
ClinicalTrials.gov ID: NCT04997109
What this study is testing
- What it's testing
- This study assesses two active treatments in different sequences and a standard of care group among infants with cerebral palsy.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 4 to 13
You may be able to join if
- Aged 4 to 13 months, corrected age
- Diagnosis of CP or classification of high-risk for CP as determined by published guidelines (\>95% risk of later CP)
- Hammersmith Infant Neurological Exam (HINE) arm asymmetry score of greater than or equal to 2 and/or neuroimaging consistent with perinatal...
- Hand Assessment for Infants (HAI) difference between hands ≥2, with an observable and relative difference in quality or amount of movement between...
- Parent/legal guardian is able to provide informed consent
You likely can't join if
- Congenital malformation of the brain or musculoskeletal system (MSK)
- Receipt of botulinum toxin to the affected extremity within 3 months of study entry
- Any prior long-term hard constraint programs
The study team makes the final eligibility decision.
Where it's taking place
- Atlanta, Georgia, United States
- Baltimore, Maryland, United States
- Philadelphia, Pennsylvania, United States
- Salt Lake City, Utah, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 4 months to 13 months. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Atlanta, Georgia, United States; Baltimore, Maryland, United States; Philadelphia, Pennsylvania, United States; Salt Lake City, Utah, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.